Literature DB >> 33394752

Double-negative T cells in autoimmune diseases.

Hao Li1, George C Tsokos.   

Abstract

PURPOSE OF REVIEW: TCRαβ+CD4-CD8- double-negative T (DNT) cells, a principal subset of mature T lymphocytes, have been closely linked with autoimmune/inflammatory conditions. However, controversy persists regarding their ontogeny and function. Here, we present an overview on DNT cells in different autoimmune diseases to advance a deeper understanding of the contribution of this population to disease pathogenesis. RECENT
FINDINGS: DNT cells have been characterized in various chronic inflammatory diseases and they have been proposed to display pathogenic or regulatory function. The tissue location of DNT cells and the effector cytokines they produce bespeak to their active involvement in chronic inflammatory diseases.
SUMMARY: By producing various cytokines, expanded DNT cells in inflamed tissues contribute to the pathogenesis of a variety of autoimmune inflammatory diseases. However, it is unclear whether this population represents a stable lineage consisting of different subsets similar to CD4+ T helper cell subset. Better understanding of the possible heterogeneity and plasticity of DNT cells is needed to reveal interventional therapeutic opportunities.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33394752      PMCID: PMC8018563          DOI: 10.1097/BOR.0000000000000778

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   4.941


  131 in total

1.  Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression.

Authors:  Z X Zhang; L Yang; K J Young; B DuTemple; L Zhang
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

2.  IL-17-producing CD4-CD8- T cells are expanded in the peripheral blood, infiltrate salivary glands and are resistant to corticosteroids in patients with primary Sjogren's syndrome.

Authors:  Alessia Alunno; Onelia Bistoni; Elena Bartoloni; Sara Caterbi; Barbara Bigerna; Alessia Tabarrini; Roberta Mannucci; Brunangelo Falini; Roberto Gerli
Journal:  Ann Rheum Dis       Date:  2012-08-17       Impact factor: 19.103

Review 3.  Activation-induced cell death in T cells and autoimmunity.

Authors:  Jian Zhang; Xuemei Xu; Yong Liu
Journal:  Cell Mol Immunol       Date:  2004-06       Impact factor: 11.530

Review 4.  The many roles of FAS receptor signaling in the immune system.

Authors:  Andreas Strasser; Philipp J Jost; Shigekazu Nagata
Journal:  Immunity       Date:  2009-02-20       Impact factor: 31.745

5.  A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.

Authors:  M C Sneller; S E Straus; E S Jaffe; J S Jaffe; T A Fleisher; M Stetler-Stevenson; W Strober
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

6.  Abnormalities induced by the mutant gene Ipr: expansion of a unique lymphocyte subset.

Authors:  H C Morse; W F Davidson; R A Yetter; E D Murphy; J B Roths; R L Coffman
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

7.  Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome.

Authors:  David T Teachey; Robert Greiner; Alix Seif; Edward Attiyeh; Jack Bleesing; John Choi; Catherine Manno; Eric Rappaport; Dirk Schwabe; Cecilia Sheen; Kathleen E Sullivan; Hongming Zhuang; Daniel S Wechsler; Stephan A Grupp
Journal:  Br J Haematol       Date:  2009-02-04       Impact factor: 6.998

8.  Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule.

Authors:  J Cheng; T Zhou; C Liu; J P Shapiro; M J Brauer; M C Kiefer; P J Barr; J D Mountz
Journal:  Science       Date:  1994-03-25       Impact factor: 47.728

9.  Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS).

Authors:  Andrea Lisco; Chun-Shu Wong; Susan Price; Peiying Ye; Julie Niemela; Megan Anderson; Elizabeth Richards; Maura Manion; Harry Mystakelis; Morgan Similuk; Bernice Lo; Jennifer Stoddard; Sergio Rosenzweig; Christophe Vanpouille; Adam Rupert; Irina Maric; Ainhoa Perez-Diez; David Parenti; Peter D Burbelo; V Koneti Rao; Irini Sereti
Journal:  Front Immunol       Date:  2019-05-29       Impact factor: 7.561

10.  Systemic lupus erythematosus favors the generation of IL-17 producing double negative T cells.

Authors:  Hao Li; Iannis E Adamopoulos; Vaishali R Moulton; Isaac E Stillman; Zach Herbert; James J Moon; Amir Sharabi; Suzanne Krishfield; Maria G Tsokos; George C Tsokos
Journal:  Nat Commun       Date:  2020-06-05       Impact factor: 14.919

View more
  9 in total

1.  T Cells in Multisystem Inflammatory Syndrome in Children (MIS-C) Have a Predominant CD4+ T Helper Response to SARS-CoV-2 Peptides and Numerous Virus-Specific CD4- CD8- Double-Negative T Cells.

Authors:  Li-En Hsieh; Jaeyoon Song; Alba Grifoni; Chisato Shimizu; Adriana H Tremoulet; Kirsten B Dummer; Jane C Burns; Alessandro Sette; Alessandra Franco
Journal:  Int J Mol Sci       Date:  2022-06-29       Impact factor: 6.208

2.  Expansion of Double-Negative T Cells in Patients before Liver Transplantation Correlates with Post-Transplant Infections.

Authors:  Hong Lei; Min Tian; Xiaogang Zhang; Xuemin Liu; Bo Wang; Rongqian Wu; Yi Lv
Journal:  J Clin Med       Date:  2022-06-17       Impact factor: 4.964

Review 3.  TCRαβ+ CD4-/CD8- "double negative" T cells in health and disease-implications for the kidney.

Authors:  Andrea M Newman-Rivera; Johanna T Kurzhagen; Hamid Rabb
Journal:  Kidney Int       Date:  2022-04-09       Impact factor: 18.998

4.  Lymphocytes in the neighborhood: good or bad for the kidney?

Authors:  Hao Li; Maria G Tsokos; George C Tsokos
Journal:  J Clin Invest       Date:  2022-07-01       Impact factor: 19.456

5.  A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn's Disease.

Authors:  Ahmed M I Elfiky; Ishtu L Hageman; Marte A J Becker; Jan Verhoeff; Andrew Y F Li Yim; Vincent W Joustra; Lieven Mulders; Ivan Fung; Inmaculada Rioja; Rab K Prinjha; Nicholas N Smithers; Rebecca C Furze; Palwinder K Mander; Matthew J Bell; Christianne J Buskens; Geert R D'Haens; Manon E Wildenberg; Wouter J de Jonge
Journal:  Cells       Date:  2022-09-12       Impact factor: 7.666

6.  Immune dysregulation associated with co-occurring germline CBL and SH2B3 variants.

Authors:  Francesco Baccelli; Davide Leardini; Edoardo Muratore; Daria Messelodi; Salvatore Nicola Bertuccio; Maria Chiriaco; Caterina Cancrini; Francesca Conti; Fausto Castagnetti; Lucia Pedace; Andrea Pession; Ayami Yoshimi; Charlotte Niemeyer; Marco Tartaglia; Franco Locatelli; Riccardo Masetti
Journal:  Hum Genomics       Date:  2022-09-19       Impact factor: 6.481

7.  Splicing factor SRSF1 is essential for CD8 T cell function and host antigen-specific viral immunity.

Authors:  Ignacio Juarez; Shi Su; Zachary T Herbert; John R Teijaro; Vaishali R Moulton
Journal:  Front Immunol       Date:  2022-09-16       Impact factor: 8.786

8.  Inherited PD-1 deficiency underlies tuberculosis and autoimmunity in a child.

Authors:  Silvia Vilarinho; Richard P Lifton; Bertrand Boisson; Laurent Abel; Dusan Bogunovic; Nico Marr; Luigi D Notarangelo; Stuart G Tangye; Tasuku Honjo; Philippe Gros; Stéphanie Boisson-Dupuis; Jean-Laurent Casanova; Masato Ogishi; Rui Yang; Caner Aytekin; David Langlais; Mathieu Bourgey; Taushif Khan; Fatima Al Ali; Mahbuba Rahman; Ottavia M Delmonte; Maya Chrabieh; Peng Zhang; Conor Gruber; Simon J Pelham; András N Spaan; Jérémie Rosain; Wei-Te Lei; Scott Drutman; Matthew D Hellmann; Margaret K Callahan; Matthew Adamow; Phillip Wong; Jedd D Wolchok; Geetha Rao; Cindy S Ma; Yuka Nakajima; Tomonori Yaguchi; Kenji Chamoto; Samuel C Williams; Jean-Francois Emile; Flore Rozenberg; Michael S Glickman; Franck Rapaport; Gaspard Kerner; Garrett Allington; Ilhan Tezcan; Deniz Cagdas; Ferda O Hosnut; Figen Dogu; Aydan Ikinciogullari; V Koneti Rao; Leena Kainulainen; Vivien Béziat; Jacinta Bustamante
Journal:  Nat Med       Date:  2021-06-28       Impact factor: 53.440

Review 9.  ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies.

Authors:  Filippo Consonni; Eleonora Gambineri; Claudio Favre
Journal:  Ann Hematol       Date:  2022-01-20       Impact factor: 3.673

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.